| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Fulcrum Therapeutics, Inc. (FULC) has 11 insiders with recent SEC Form 4 filings, including 4 buys and 9 sells. FULC is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 8.85M | $62.67M | - | |
| Dir | 469.9K | $3.33M | - | |
| Dir | 36.0K | $254.9K | - | |
| Dir | 36.0K | $254.9K | - | |
| Dir | 36.0K | $254.9K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 10, 2021 | Moxham Christopher | Chief Scientific Officer | Sale+OE | 51,785 | $17.60 | $911,416.00 | -100% | +8.1% | -58.7% | |
| Jun 28, 2021 | Oltmans Curtis Gale | SVP, General Counsel | Buy | 1,088 | $9.01 | $9,802.88 | New | +202.6% | -46.2% | |
| Jun 28, 2021 | Morabito Christopher61 | Chief Medical Officer | Buy | 1,100 | $9.16 | $10,076.00 | New | +202.6% | -46.2% | |
| Jun 28, 2021 | Thomson Peter G. | VP Finance &Accounting | Buy | 2,300 | $9.00 | $20,700.00 | New | +202.6% | -46.2% | |
| Jun 28, 2021 | Geraghty James A | Director | Buy | 10,000 | $9.16 | $91,600.00 | +12.4% | +202.6% | -46.2% | |
| Mar 16, 2021 | Gould Robert J85 | See Remarks | Sell | 10,000 | $12.16 | $121,578.33 | -1.0% | -28.7% | +41.5% | |
| Feb 22, 2021 | Thomson Peter G. | VP Finance &Accounting | Sale+OE | 5,000 | $14.72 | $73,581.50 | -24.7% | - | - | |
| Feb 16, 2021 | Gould Robert J85 | See Remarks | Sell | 8,215 | $14.27 | $117,197.40 | -0.8% | - | - | |
| Jan 21, 2021 | Thomson Peter G. | VP Finance &Accounting | Sell | 6,607 | $14.00 | $92,498.00 | -30.3% | - | - | |
| Jan 20, 2021 | Gould Robert J85 | See Remarks | Sell | 10,000 | $12.08 | $120,826.00 | -1.9% | - | - |